TMS Co.,Ltd.

ティムス

Industry: Pharmaceutical
Market: Growth
Accounting standards: Japanese GAAP
Consolidation basis: Non-consolidated

Notes

Fiscal period change
Dec 2025 / 10-month fiscal period

Key metrics

Revenue(-)

Feb 2023

Feb 2024

Feb 2025

Dec 2025

10-month fiscal period

Operating profit(thousand JPY)

Feb 2023

-520,149

Feb 2024

-943,253

Feb 2025

-907,791

Dec 2025

10-month fiscal period

-696,973

Operating profit margin(-)

Feb 2023

Feb 2024

Feb 2025

Dec 2025

10-month fiscal period

Profit before tax(thousand JPY)

Feb 2023

-861,471

Feb 2024

-959,090

Feb 2025

-659,598

Dec 2025

10-month fiscal period

-715,267

Profit(thousand JPY)

Feb 2023

-860,925

Feb 2024

-960,040

Feb 2025

-660,548

Dec 2025

10-month fiscal period

-716,058

Total assets(thousand JPY)

Feb 2023

3,790,215

Feb 2024

3,554,754

Feb 2025

3,032,269

Dec 2025

10-month fiscal period

2,865,277

Cash and cash equivalents(thousand JPY)

Feb 2023

3,584,667

Feb 2024

3,446,630

Feb 2025

2,922,950

Dec 2025

10-month fiscal period

2,781,032

Cash flows from operating activities(thousand JPY)

Feb 2023

-688,423

Feb 2024

-822,814

Feb 2025

-493,756

Dec 2025

10-month fiscal period

-779,890

Cash flows from investing activities(thousand JPY)

Feb 2023

-13,721

Feb 2024

-3,356

Feb 2025

-30,843

Dec 2025

10-month fiscal period

-2,544

Cash flows from financing activities(thousand JPY)

Feb 2023

1,688,809

Feb 2024

688,133

Feb 2025

919

Dec 2025

10-month fiscal period

640,516

Return on equity(%)

Feb 2023

-27.9

Feb 2024

-26.8

Feb 2025

-23.7

Dec 2025

10-month fiscal period

-25.9

Equity ratio(%)

Feb 2023

Feb 2024

96.9

Feb 2025

92.1

Dec 2025

10-month fiscal period

95.5

Earnings per share(JPY per share)

Feb 2023

-25.28

Feb 2024

-26.02

Feb 2025

-16.38

Dec 2025

10-month fiscal period

-16.08

Net assets per share(JPY per share)

Feb 2023

101.55

Feb 2024

85.48

Feb 2025

69.23

Dec 2025

10-month fiscal period

60.14

Dividend per share(-)

Feb 2023

Feb 2024

Feb 2025

Dec 2025

10-month fiscal period

Payout ratio(-)

Feb 2023

Feb 2024

Feb 2025

Dec 2025

10-month fiscal period

Disclaimer

The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.

The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.